Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yu-Tzu Tai

Showing results (31-40 of 211) with videos related to

Pageof 22
Sort By:
Antibodies (Basel, Switzerland)|September 25, 2019
Monoclonal Antibody: A New Treatment Strategy against Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
British Journal of Haematology|June 24, 2017
MUC1-C is a target in lenalidomide resistant multiple myelomaLi Yin, Ashujit Tagde, Reddy Gali, et al.
British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.
Cancer Genomics & Proteomics|March 9, 2012
Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growthJagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, et al.
Leukemia|April 15, 2024
Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumorsJooeun Bae, Teru Hideshima, Yu-Tzu Tai, et al.
Cancer Discovery|June 18, 2015
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive MyelomaFrancesca Cottini, Teru Hideshima, Rikio Suzuki, et al.
Microsurgery|February 21, 2008
Penile replantation, complication management, and technique refinementErh-Kang Chou, Yu-Tzu Tai, Chao-I Wu, et al.
Leukemia|March 1, 2018
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumorsJooeun Bae, Teru Hideshima, Yu-Tzu Tai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2017
Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple MyelomaXiaoyan Feng, Li Zhang, Chirag Acharya, et al.
Pageof 22

Showing results (31-40 of 211) with videos related to

Sort By:
Pageof 22
Antibodies (Basel, Switzerland)|September 25, 2019
Monoclonal Antibody: A New Treatment Strategy against Multiple MyelomaShih-Feng Cho, Liang Lin, Lijie Xing, et al.
British Journal of Haematology|June 24, 2017
MUC1-C is a target in lenalidomide resistant multiple myelomaLi Yin, Ashujit Tagde, Reddy Gali, et al.
British Journal of Haematology|April 27, 2012
A novel immunogenic CS1-specific peptide inducing antigen-specific cytotoxic T lymphocytes targeting multiple myelomaJooeun Bae, Weihua Song, Robert Smith, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|July 4, 2012
Myeloma-specific multiple peptides able to generate cytotoxic T lymphocytes: a potential therapeutic application in multiple myeloma and other plasma cell disordersJooeun Bae, Robert Smith, John Daley, et al.
Cancer Genomics & Proteomics|March 9, 2012
Targeting PI3K and RAD51 in Barrett's adenocarcinoma: impact on DNA damage checkpoints, expression profile and tumor growthJagannath Pal, Mariateresa Fulciniti, Puru Nanjappa, et al.
Leukemia|April 15, 2024
Correction to: Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumorsJooeun Bae, Teru Hideshima, Yu-Tzu Tai, et al.
Cancer Discovery|June 18, 2015
Synthetic Lethal Approaches Exploiting DNA Damage in Aggressive MyelomaFrancesca Cottini, Teru Hideshima, Rikio Suzuki, et al.
Microsurgery|February 21, 2008
Penile replantation, complication management, and technique refinementErh-Kang Chou, Yu-Tzu Tai, Chao-I Wu, et al.
Leukemia|March 1, 2018
Histone deacetylase (HDAC) inhibitor ACY241 enhances anti-tumor activities of antigen-specific central memory cytotoxic T lymphocytes against multiple myeloma and solid tumorsJooeun Bae, Teru Hideshima, Yu-Tzu Tai, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|March 3, 2017
Targeting CD38 Suppresses Induction and Function of T Regulatory Cells to Mitigate Immunosuppression in Multiple MyelomaXiaoyan Feng, Li Zhang, Chirag Acharya, et al.
Pageof 22